All tenders
BidLive · 13 days leftVerified details

GEM/2026/B/7810507

Emicizumab inj. 30mg 1.0ml A,Emicizumab inj. 30mg 1.0ml B,Emicizumab inj. 30mg 1.0ml C,Emicizumab i

Published

20 Jul 2026, 03:49 pm

Closes

11 Aug 2026, 09:00 am

Pre-bid meet

Bid opening

11 Aug 2026, 09:30 am

Financial details

Estimated value
EMD amount
ePBG %
Advisory bank
Evaluation methodItem wise evaluation
Bid validity180 days

Buyer details

MinistryMinistry of Health and Family Welfare
DepartmentDepartment of Health Research
OrganisationIndian Council Of Medical Research (icmr)
OfficeMumbai

BoQ items (5)

#ItemDescriptionQtyUnit
Schedule 1Emicizumab Inj. 30mg 1.0ml A10
Schedule 2Emicizumab Inj. 30mg 1.0ml B10
Schedule 3Emicizumab Inj. 30mg 1.0ml C10
Schedule 4Emicizumab Inj. 60mg 0.4ml A5
Schedule 5Emicizumab Inj. 60mg 0.4ml B5

Consignees (5)

#ConsigneeAddressQtyDelivery (days)
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai1030
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai1030
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai1030
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai530
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai530

Exemptions & flags

MSE exemption
Startup exemption
OEM required

Quick facts

Bid ID9633726
Quantity40
Status1
Details fetched21 Jul 2026, 11:15 am